NovoCure Cash Flow from Investing Activities 2014-2024 | NVCR
NovoCure cash flow from investing activities from 2014 to 2024. Cash flow from investing activities can be defined as the total change in cash resulting from a companies investments
| NovoCure Annual Cash Flow Investing (Millions of US $) |
|
|---|---|
| 2023 | $184 |
| 2022 | $-140 |
| 2021 | $-145 |
| 2020 | $-473 |
| 2019 | $-52 |
| 2018 | $-5 |
| 2017 | $9 |
| 2016 | $13 |
| 2015 | $-115 |
| 2014 | $-46 |
| 2013 | $10 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $2.397B | $0.509B |
| NovoCure Limited is an oncology company. The Company is engaged in developing a therapy called Tumor Treating Fields for the treatment of solid tumor cancers. It operates primarily in the United States, Germany, Switzerland and Japan. NovoCure Limited is based in Saint Helier, Channel Islands. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elevance Health (ELV) | United States | $117.915B | 14.80 |
| Cencora (COR) | United States | $43.985B | 17.15 |
| ICON (ICLR) | Ireland | $26.639B | 25.15 |
| DiDi Global (DIDIY) | China | $22.358B | 0.00 |
| Avantor (AVTR) | United States | $16.031B | 23.60 |
| CochLear (CHEOY) | Australia | $13.625B | 0.00 |
| Natera (NTRA) | United States | $13.523B | 0.00 |
| Revvity (RVTY) | United States | $13.368B | 23.45 |
| Viatris (VTRS) | United States | $12.478B | 3.73 |
| Medpace Holdings (MEDP) | United States | $11.950B | 39.32 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $11.358B | 0.00 |
| Charles River Laboratories (CRL) | United States | $10.803B | 20.68 |
| Solventum (SOLV) | United States | $10.078B | 0.00 |
| Sonic Healthcare (SKHHY) | Australia | $7.710B | 0.00 |
| HealthEquity (HQY) | United States | $6.884B | 50.72 |
| Bausch + Lomb (BLCO) | Canada | $5.410B | 21.68 |
| Organon (OGN) | United States | $5.385B | 5.11 |
| Doximity (DOCS) | United States | $5.177B | 36.04 |
| PACS (PACS) | United States | $4.499B | 0.00 |
| Surgery Partners (SGRY) | United States | $3.467B | 31.72 |
| Life Times (LTH) | United States | $3.279B | 34.35 |
| Sotera Health (SHC) | United States | $3.139B | 15.40 |
| GoodRx Holdings (GDRX) | United States | $2.837B | 108.00 |
| Agilon Health (AGL) | United States | $2.566B | 0.00 |
| Progyny (PGNY) | United States | $2.535B | 43.64 |
| AMN Healthcare Services Inc (AMN) | United States | $2.064B | 8.18 |
| Premier (PINC) | United States | $1.985B | 8.49 |
| BrightSpring Health Services (BTSG) | United States | $1.962B | 0.00 |
| Teladoc Health (TDOC) | United States | $1.915B | 0.00 |
| Ryman Healthcare (RYHTY) | New Zealand | $1.566B | 0.00 |
| Alignment Healthcare (ALHC) | United States | $1.507B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.420B | 0.00 | |
| Embecta (EMBC) | United States | $0.717B | 4.87 |
| CareDx (CDNA) | United States | $0.704B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.645B | 0.00 |
| Pediatrix Medical (MD) | United States | $0.619B | 6.57 |
| InnovAge Holding (INNV) | United States | $0.589B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.583B | 15.27 |
| GeneDx Holdings (WGS) | United States | $0.533B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.507B | 0.00 |
| Enhabit (EHAB) | United States | $0.461B | 46.00 |
| ModivCare (MODV) | United States | $0.403B | 7.54 |
| Sonida Senior Living (SNDA) | United States | $0.383B | 0.00 |
| LifeMD (LFMD) | United States | $0.359B | 0.00 |
| MultiPlan (MPLN) | United States | $0.348B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.324B | 0.00 |
| Sharecare (SHCR) | United States | $0.306B | 0.00 |
| DocGo (DCGO) | United States | $0.300B | 16.39 |
| Beauty Health (SKIN) | United States | $0.270B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.223B | 0.00 |
| Biodesix (BDSX) | United States | $0.155B | 0.00 |
| So-Young (SY) | China | $0.104B | 52.50 |
| Pono Capital Two (PTWO) | United States | $0.071B | 0.00 |
| NeueHealth (NEUE) | United States | $0.050B | 6.71 |
| IceCure Medical (ICCM) | Israel | $0.048B | 0.00 |
| Oncology Institute (TOI) | United States | $0.035B | 0.00 |
| Nutex Health (NUTX) | United States | $0.033B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.033B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.028B | 0.00 |
| Singular Genomics Systems (OMIC) | United States | $0.027B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.026B | 0.00 |
| OncoCyte (OCX) | United States | $0.022B | 0.00 |
| BIMI Holdings (BIMI) | United States | $0.013B | 0.00 |
| DermTech (DMTK) | United States | $0.011B | 0.00 |
| TRxADE HEALTH (MEDS) | United States | $0.010B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.008B | 0.00 | |
| Intelligent Bio Solutions (INBS) | United States | $0.008B | 0.00 |
| XWELL (XWEL) | United States | $0.007B | 0.00 |
| NewGenIvf Group (NIVF) | Singapore | $0.005B | 0.00 |
| OpGen (OPGN) | United States | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.004B | 0.00 |
| Assure Holdings (IONM) | United States | $0.003B | 0.00 |
| Aclarion (ACON) | United States | $0.003B | 0.00 |